PTC Therapeutics, Inc. Inventory, Finished Goods, Gross
PTC Therapeutics, Inc. (PTCT) had Inventory, Finished Goods, Gross of $23.06 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryFinishedGoods · last filed 2026-07-30
- 2026-06-30: Inventory, Finished Goods, Gross $23.06M.
- 2026-03-31: Inventory, Finished Goods, Gross $21.16M.
- 2025-12-31: Inventory, Finished Goods, Gross $21.67M.
- 2025-09-30: Inventory, Finished Goods, Gross $8.62M.
| Period end | Inventory, Finished Goods, Gross |
|---|---|
| 2026-06-30 | $23.06M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $21.16M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $21.67M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $8.62M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $7.51M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $6.51M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $8.44M 10-K · filed 2026-02-19 |
| 2024-09-30 | $8.49M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $6.68M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $6.76M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $11.63M 10-K · filed 2025-02-27 |
| 2023-09-30 | $10.25M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $10.04M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $7.11M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $6.66M 10-K · filed 2024-02-29 |
| 2022-09-30 | $6.51M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $6.59M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $5.71M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $6.72M 10-K · filed 2023-02-21 |
| 2021-09-30 | $6.13M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $6.91M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $7.16M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $9.13M 10-K · filed 2022-02-22 |
| 2020-09-30 | $9.94M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $8.83M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $8.78M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $8.76M 10-K · filed 2021-02-25 |
| 2019-09-30 | $4.38M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $6.47M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $6.51M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $5.36M 10-K · filed 2020-03-02 |
| 2018-09-30 | $7.26M 10-Q · filed 2018-11-05 |
| 2018-06-30 | $8.41M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $6.80M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $6.39M 10-K · filed 2019-03-01 |
| 2017-09-30 | $4.89M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $5.97M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.03M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |